EndoDrill GI Success in Porto
- BiBBInstruments AB, a cancer diagnostics company, announced a successful live demonstration of its EndoDrill® GI.
- The procedure took place at Hospital Pedro Hispano adn was broadcast live during the annual meeting of the Portuguese Association for Gastrointestinal Endoscopy, Live Sped 2025.
- The live case was performed by Dr. Francisco Baldaque Silva, head of gastroenterology at Hospital Pedro Hispano in porto and senior physician at Karolinska University Hospital (KS)...
EndoDrill® GI Showcased in Live Biopsy Procedure
Table of Contents
BiBBInstruments AB, a cancer diagnostics company, announced a successful live demonstration of its EndoDrill® GI. This device,the worldS first market-approved electric-powered biopsy instrument for endoscopy,was used in a pancreatic tumor sampling on a patient in Porto,Portugal.
The procedure took place at Hospital Pedro Hispano adn was broadcast live during the annual meeting of the Portuguese Association for Gastrointestinal Endoscopy, Live Sped 2025. This event served as a crucial test for the innovative product.
Live Demonstration Highlights EndoDrill® GI’s Efficiency
The live case was performed by Dr. Francisco Baldaque Silva, head of gastroenterology at Hospital Pedro Hispano in porto and senior physician at Karolinska University Hospital (KS) in Stockholm. the BiBB team was present to witness the procedure.
Live broadcasts expose both the advantages and disadvantages of new medical technology in real-time. The EndoDrill® GI procedure was a success,garnering positive feedback from the team and audience who appreciated the high-quality core biopsies obtained.
Dr. Baldaque Silva proposed the live biopsy procedure after using EndoDrill® GI at both KS and Hospital Pedro Hispano.
It is indeed encouraging to see how well EndoDrill® GI fits into current clinical workflow and how effectively it can be used to take high-quality biopsies,
Dr. Charles Walther, founder and CMO of bibb
About EndoDrill® GI
endodrill® GI is the world’s first market-approved electric-powered biopsy instrument for endoscopic ultrasound (EUS). It facilitates EUS-guided tissue sampling for various indications in the gastrointestinal tract, including the pancreas, stomach, esophagus, lymph nodes, and liver.
The device received FDA 510(k) clearance in the USA in 2023 and CE approval in Europe in early 2024. Currently, EndoDrill® GI is undergoing clinical evaluation in both the USA and Europe. The commercialization phase began in early 2025, marked by an initial order from a university hospital in the USA.
BiBBInstruments: Advancing Cancer Diagnostics
BiBBInstruments AB develops and manufactures EndoDrill®, a patented series of electric-powered endoscopic biopsy instruments. These instruments aim to improve the diagnosis of severe cancers by taking high-quality tissue samples with precision.
The product portfolio targets the global market for ultrasound-guided endoscopic (EUS/EBUS) biopsy instruments,a rapidly growing area within endoscopy. BiBB received FDA 510(k) approval for EndoDrill® GI in 2023. In early 2024, it also obtained CE marking according to MDR for all three product variants: EndoDrill® GI, endodrill® EBUS, and EndoDrill® URO.
This makes EndoDrill® the first market-approved electric-powered endoscopic biopsy system in both the USA and Europe. The system includes sterile, single-use biopsy instruments with a corresponding drive unit. Founded in 2013, BiBBInstruments is based in Medicon Village in Lund, with its stock (ticker: BIBB) listed on Spotlight Stock Market.
EndoDrill® GI: Your Questions Answered About This Innovative Biopsy Device
EndoDrill® GI is making waves in the field of cancer diagnostics. This Q&A-style article addresses common questions about this groundbreaking device, its use, and the company behind it.
What is EndoDrill® GI?
EndoDrill® GI is the world’s first market-approved, electric-powered biopsy instrument designed for endoscopic ultrasound (EUS). It’s used to obtain tissue samples within the gastrointestinal tract,aiding in the diagnosis of various conditions,including cancer.
What are the key benefits of using EndoDrill® GI for biopsies?
The EndoDrill® GI offers several advantages:
High-Quality Samples: It is designed to take high-quality tissue samples, which are crucial for accurate diagnoses. The live presentation highlighted the device’s ability to obtain excellent core biopsies.
Precision: The electric-powered system allows for precise tissue sampling.
Versatility: It can be used for sampling in various organs of the gastrointestinal tract,including the pancreas,stomach,esophagus,lymph nodes,and liver.
Efficiency: It is designed to fit effectively into current clinical workflows.
Increased Accuracy: A pilot clinical study showed that EndoDrill® GI provided 100% diagnostic accuracy
How does EndoDrill® GI work?
EndoDrill® GI is used in conjunction with endoscopic ultrasound (EUS). EUS allows doctors to visualize areas within the gastrointestinal tract that are challenging to see with traditional endoscopy. The EndoDrill® GI, guided by the ultrasound image, then precisely obtains tissue samples for pathological analysis. it is a system comprised of sterile, single-use biopsy instruments along with a corresponding drive unit.
Were is EndoDrill® GI currently available?
EndoDrill® GI has received regulatory clearance in both the United States and Europe:
USA: FDA 510(k) clearance was granted in 2023.
* Europe: CE marking (MDR) was obtained in early 2024.
As of early 2025, the device is in the commercialization phase, with initial orders placed by university hospitals in the USA. Clinical evaluations are also ongoing in both the USA and Europe.
What is BiBBInstruments and what is their mission?
BiBBInstruments AB is a Swedish cancer diagnostics company that develops and manufactures the EndoDrill® series of electric-powered endoscopic biopsy instruments. Their mission is to improve the diagnosis of severe cancers by enabling the collection of high-quality tissue samples with greater precision. bibbinstruments is based in Medicon Village in Lund, and its stock (ticker: BIBB) is listed on Spotlight Stock Market.
What is the importance of the live demonstration in Porto?
the live demonstration of EndoDrill